Saturday, May 31, 2008

Miracle man says embryonic stem-cell therapy works

http://www.news.com.au/heraldsun/story/0,21985,23778831-2862,00.html

Article from: Herald Sun
Grant McArthurLouis Rowe
Louis Rowe
Up and at 'em: Louis Rowe gets a kiss from mum Vivienne. Picture Craig Borrow

May 30, 2008 12:00am

LOUIS Rowe says he is living, walking proof that embryonic stem-cell therapy works.

And there are plenty of other Victorians keen to follow his footsteps to India in the hope of a miracle.

The 23-year-old paraplegic returned from New Delhi last Thursday after having the treatment he believes has put him back on his feet.

Mr Rowe was left a paraplegic after severing his spinal cord in a motorbike accident in Thailand last year, with no feeling, movement or function below his hips.

With the help of calipers to heavily brace his legs, he can now stand and shuffle around his Docklands apartment, and says he is slowly regaining feeling in his legs thanks to Indian gynaecologist Geeta Shroff.

Over the course of nine weeks, Dr Shroff injected twice-daily doses of embryonic stem cells into Mr Rowe's arm, as well as five larger courses of 50 million cells directly into his spine.

While many Australian and international scientists have been critical of the treatment, stem-cell experts declined to comment about the latest apparent success because there is yet to be any clinical research to prove or disprove the claims.

The initial $45,000 treatment will be followed up with at least two further treatments in India over the next nine months.

"I've got the feeling back. It's not complete at the moment but it is starting to get there," Mr Rowe said.

"One morning I woke up over there and my foot was against the cold steel hospital bed and I was able to feel that, and that was when I realised it was working."

Mr Rowe was one of five Australians being treated by Dr Shroff at her Nu-tech Mediworld in the last two months.

They also include quadriplegic Perry Cross, who can breathe without a ventilator and sit unaided for the first time in 14 years.

A St Kilda multiple sclerosis sufferer, a Lakes Entrance woman with motor neurone disease and a Brisbane paraplegic have also travelled to India, hoping for a cure from Dr Shroff.

In the days since his return, Mr Rowe has received emails and calls from a dozen miracle seekers.

He has met a man and a woman from Melbourne who are travelling to the New Delhi clinic next month to see if embryonic stem cells can cure their paraplegia.

Since developing her technique, Dr Shroff has treated more than 500 patients with stem cells derived from a single embryo derived from an IVF patient.

Mr Rowe's mother Vivienne is ecstatic about his improvement.

"We all feel a lot better because there is just so much hope," Ms Rowe said.

"To see him stand for the first time and take steps, was just the most amazing thing -- like he'd been born again.

"I always knew he would walk. I knew there was technology out there."

http://www.news.com.au/heraldsun/story/0,21985,23778831-2862,00.html


http://www.nationalmssociety.org/index.aspx
Immune System / Vaccines News
Biojector(R)2000 Technology Put To The Test In CDC Flu Vaccine Study
Bioject Medical Technologies Inc. (Nasdaq:BJCT), a leading developer of needle-free injection therapy ("NFIT") systems, announced that the Biojector®2000 ("B2000") needle-free system has advanced to Phase II in a clinical study sponsored by the Centers for Disease Control and Prevention ("CDC").


New Book Demystifies The World Of Clinical Trials
Researchers, patients, and even clinical trials managers are often bewildered by the Byzantine rules and regulations governing clinical trials. Keeping it all straight and up-to-date has, until now, been challenging.
Ibuprofen, Aspirin, Naproxen May Be Equally Effective At Reducing Risk Of Alzheimer's Disease
Different types of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin, appear to be equally effective in lowering the risk of Alzheimer's disease, according to the largest study of its kind published in the May 28, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Key To Angelina-Like Cheeks? Add Volume To Deep Fat Compartment
Not only are cheeks central to your face - they are central to the American concept of beauty. A study in June's Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), found that a deep fat compartment located within the cheek is vital to a youthful-looking face.
Preventing Diabetes With The Traditional Mediterranean Diet
A study published on bmj.comreports that the traditional Mediterranean diet - one rich in oliveoil, grains, fruits, nuts, vegetables, and fish, but low in alcohol,dairy, and meat products - protects individuals from type 2 diabetes(also known as adult-onset diabetes).

Oral Drug From Novartis/Mitsubishi Tanabe Will Capture The
Pharmaceutical Online (press release) - Erie,PA,USA
... also finds that other strong contenders in the multiple sclerosis market over the next 10 years will include Merck Serono's oral cladribine (Mylinax), ...
See all stories on this topic

Elan "add"
newratings.com - Westerburg,Germany
NEW YORK, May 27 (newratings.com) - Analyst Ian Hunter of Goodbody Stockbrokers maintains his "add" rating on Elan Corp Plc (ELN). ...
See all stories on this topic

Taylor has a vision for the blind
Crossville Chronicle - Crossville,TN,USA
First, the host Montel Williams has been diagnosed with MS himself. Second, the show has done quality programs in informing people about various diseases ...
See all stories on this topic

'Sharing Miracles' Television Program to Feature Pop Icon and ...
PharmaLive.com (press release) - Newtown,PA,USA
... and Bruce Jenner (attention deficit disorder); and syndicated television talk show host Montel Williams, who suffers from multiple sclerosis. ...
See all stories on this topic

He’s just making it up as he goes along
News & Star - Carlisle,England,UK
... Lee Simpson and Mike McShane, who is replacing improv stalwart Jim Sweeney, now too unwell with the multiple sclerosis to carry on touring. ...
See all stories on this topic





Treatment

Dr. Yeung

Director MS Clinical Trials Research Unit Foothills MS Clinic, Calgary


View BIO

Q :
My daughter (18 years old) has been diagnosed with clinically isolated syndrome (CIS) and she is in a clinical trial. One of the conditions of the study is that she not get pregnant during this time as the medication may cause a miscarriage. If she stays on this type of medication can she ever get pregnant? She has just realized that she may never have children and has always wanted them.
A :
Most medications being tested in clinical trials (regardless of disease) require that patients don't get pregnant, and, depending upon the medication, not father children. This is because these medications could potentially affect either the pregnancy or the fetus itself.

It's difficult to comment specifically about this clinical trial; however, in the majority of cases where medication can affect pregnancy, the medication can be discontinued or possibly changed prior to attempting conception. This should be discussed with your neurologist who can help determine the best course of action. Your neurologist can also discuss the effects of pregnancy and the post-partum period on multiple sclerosis.

5/31/2008 12:57:09 AM


More answers from Dr. Michael Yeung

More answers in the category: Treatment


DISCLAIMER: Please be aware that this information does not necessarily represent the opinion of the MS Society of Canada, and is not intended as medical advice. For specific advice and opinion, always consult a physician.

© 2008 Multiple Sclerosis Society of Canada
| www.mssociety.ca
http://www.msanswers.ca/QuestionView.aspx?L=2&QID=1817


Advancing slowly: Local biotech ideas are evolving into companies ...
Bizjournals.com - Charlotte,NC,USA
The rat was treated with ground-breaking technology, using stem cells harvested from a nasal cavity to repair the injury. Heading up the research is Fred ...
See all stories on this topic

Pluristem Demonstrates the Potential of Its PLX Cells to Treat Crohn's Disease and Ulcerative Colitis
Centre Daily Times - Centre,PA,USA
As a cellular therapy, our PLX cells, that are derived from human placenta, a non-controversial, non-embryonic, adult stem cell source and are stored ...
See all stories on this topic

Friday, May 30, 2008

Rain Pryor Continues Her Father's Legacy

More Information About MS

More Information About Pryor Experience

BALTIMORE (WJZ) ―

Even in death, Richard Pryor is considered a comedic icon. Now, three years after losing his battle with multiple sclerosis, his daughter is continuing her father's legacy.

Healthwatch reporter Kellye Lynn reports Rain Pryor is an actress, comedienne, author and singer who for years has been sharing her talents with audiences around the world. In June, she will perform at the Hippodrome to raise money in the fight against MS.

At 38, Rain Pryor finally has her life where she wants it. She's comfortable with whom she is, where she is professionally and personally.

"I have a family here that's amazing and brilliant and a whole life that is so calm and so much of who I truly am," said Pryor.

Nearly two years ago, Rain packed up and headed east for a fresh start in Baltimore. That's a stark contrast to her roller coaster upbringing in Hollywood.

Raised by her former go-go dancer mom and Jewish grandparents, Rain didn't meet her legendary father until she was four. It was at times a rocky relationship. Then in 1986, two years after she first appeared in the television series "Head of the Class," her father got the life-altering diagnosis. It was multiple sclerosis.

"How he discovered MS is he got terrible, terrible headaches," said Pryor.

Multiple sclerosis is a chronic, inflammatory disease that affects about 400,000 Americans. In MS, the immune cells attack the outer covering of the nerves, leaving sufferers with tingling, numbness, loss of strength, dizziness, fatigue and double vision.

"The problem with MS is that one's immune system is overactivated and it's activated against the nervous system," said Dr. Walter Royal, University of Maryland Medical Center.

Dr. Walter Royal is a researcher at the Maryland Center for MS. He explains there is no cure for the disease and current drugs are only effective in a third of patients. Scientists in Baltimore are working to develop new drugs and to explore the potential of therapies like Vitamin D.

"People who live in areas where Vitamin D intake is low may be at higher risk of multiple sclerosis," said Dr. Royal.

Since her father's near 20-year struggle with MS ended in 2005, Rain has accepted that call. She uses her celebrity to help researchers get closer to a cure.

"Anytime I walk into a room and see someone with MS, I'm affected by it. I know what their kids are going through, I know what their caretaker is going through. So it's a journey that has to continue and needs a voice," said Pryor.

Rain performs June 6 at the Hippodrome Theatre to raise money for MS research. Her jazz cabaret show is called "Pryor Experience."

Rain just gave birth to a beautiful daughter named Lotus in April. Mother and baby are doing just fine.

(© MMVIII, CBS Broadcasting Inc. All Rights Reserved.)

http://wjz.com/local/rain.pryor.comedy.2.735848.html

Thursday, May 29, 2008



Ms. Harris

Nurse Co-ordinator/Nurse Practitioner, University of Calgary, MS Clinic


View BIO

Q :
I am highly skeptical of naturopathic therapies for MS, but have some friends who are strongly recommending naturopathic medicine. I understand that naturopaths have a variety of services available: chelation, nutritional counseling, acupuncture, spinal adjustments, and injection therapies, to name a few. Is there any type of naturopathic medicine that you would recommend at all? Am I wrong to be so skeptical or am I missing something that could actually help my husband's symptoms?
A :
It is always wise to be an informed consumer of health care whether it is for medical care delivered by your health care system or some of the many alternative or complementary therapies. It is important to understand the rationale for all treatments. Naturopathic treatments and practitioners are not regulated and there is no way of knowing if they have caused harm to anyone or if they are delivering what they are promising. If you visit the internet you can find countless claims of products and procedures that are advertised to cure illness or make life easier. Many of these are very expensive and when individuals perceive their life to be hopeless they often fall prey to false advertisement that greatly impacts their personal finances.

In modern medicine we like to follow evidence based practice. This means we use treatments that have been researched in clinical trials and been proven to impact the illness they are being used in. This gives us an opportunity to evaluate the safety of the treatments as well. Without this process it is very hard to recommend therapies that could cause harm someone or be costly and not produce benefit. Many individuals chose to follow an alternate path and see naturopaths but must do so at their own risk which means if things go wrong they are on their own.

Recently the gap between modern medicine and more traditional heath practices of eastern medicine are being bridged through research and we are finding evidence to promote such practices as acupuncture. Modern health practitioners are becoming more open minded and working on controlled trials to determine effectiveness of oral products such as herbs and vitamins as well as physical therapy treatments. It is a trend that is likely to continue in the future but until we have knowledge that these treatments can help it is everyone’s responsibility to be wise consumers.

5/29/2008 9:05:47 AM


More answers from Ms. Colleen Harris

More answers in the category: Complementary and Alternative Therapies


DISCLAIMER: Please be aware that this information does not necessarily represent the opinion of the MS Society of Canada, and is not intended as medical advice. For specific advice and opinion, always consult a physician.

© 2008 Multiple Sclerosis Society of Canada
Vaccine reverses diabetes in mice
Pittsburgh Tribune-Review - Pittsburgh,PA,USA
By Luis F�bregas An experimental vaccine has prevented and reversed type 1 diabetes in laboratory animals, researchers at Children's Hospital of Pittsburgh ...
See all stories on this topic

From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases.

From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases.

This paper gives an overview of the remyelinating process comparing different species, including humans. They focus on the fact that fish are more efficient at repairing some parts of their central nervous system than people and what we can learn from this.

authors: Dubois-Dalcq M, Williams A, Stadelmann C, Stankoff B, Zalc B, Lubetzki C.

source: Brain. 2008 May 12 [Epub ahead of print]

read

UK MS Society article on a decade in the ‘life’ of MS available now

Alan Thompson, Director of the Institute of Neurology in London and Chairman of MSIF’s International Medical and Scientific Board (IMSB), has written an article for the UK MS Society, looking at changes in MS, including understanding of the disease, treatment strategies and advances in MS research over the past 10 years.

read mor

Plan to promote pan-European standards in MS care

In Lubljana on May 7, neurologists, policy makers, and patients' groups came together for a roundtable discussion organised by the European Multiple Sclerosis Platform (EMSP) concerning pan-European inequalities in access to treatments for people with MS. The results of the pan-European MS Barometer study were presented and discussed among high level representatives from the EU institutions, Slovenian government and the medical profession.

read more


FTY720

Approval for Novartis' generic Betaferon in EU
Therapeutics Daily (subscription) (press release) - Newtown,PA,USA
Swiss drug major Novartis has received approval from the European Commission for Extavia (interferon beta-1b), its generic version of Bayer Schering's ...
See all stories on this topic

Novartis Looks For Magic Pill
Forbes - NY,USA
The Swiss drugmaker Novartis has been given the green light by the European Commission to sell Extavia, a multiple sclerosis drug. And although the firm has ...
See all stories on this topic

Novartis gets approval to sell interferon beta-1b in Europe
Pharma Times (subscription) - London,UK
... first step in getting a foothold in the MS market


Facing the Cognitive Challenges of Multiple Sclerosis
Jeffrey Gingold's book, Facing the Cognitive Challenges of Multiple Sclerosis, is an emotional and well-written account of life with one of the most common symptoms of MS - cognitive dysfunction. In telling his story, Gingold gives honest and practical advice about dealing with the frustrations of this "invisible" symptom of MS.

Read the full review here.

MS and Your Feelings
MS and Your Feelings: Handling the Ups and Downs of Multiple Sclerosis by Allison Shadday is the first book to deal exclusively with the emotional impact of MS. If I was to recommend one book about MS, this would be it.

Read the full review here.


MS in focus: Spasticity survey

Our next issue of MS in focus will be on MS and spasticity and we have created a survey for people with MS who experience spasticity.
Results and experiences will be collated and written up for MS in Focus, due out Summer 2008.

read more

Long term clinical relevance of criteria for designating Multiple Sclerosis as benign after ten years of disease.

In this study the authors followed a large group of people with MS for more than 20 years to assess the evolution of the disease particularly focusing on those with benign MS. 26 years after onset 11% of people had minimal disability suggestive of benign MS and this was associated with female sex, younger age of onset and absence of motor symptoms at presentation.

authors: Costelloe L, Thompson A, Walsh C, Tubridy N, Hutchinson M.

source: J Neurol Neurosurg Psychiatry. 2008 May 13 [Epub ahead of print]

read more

Cognitive and psychosocial features of childhood and juvenile MS.

The authors assessed the cognitive and psychosocial abilities of children and adolescents with MS. They found that more than half of these people had difficulties in school and everyday activities. The authors concluded therefore that this is an area of critical importance to focus on to help them to manage better.

authors: Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, Moiola L, Falautano M, De Caro MF, Lopez M, Patti F, Vecchio R, Pozzilli C, Bianchi V, Roscio M, Comi G, Trojano M; Multiple Sclerosis Study Group of the Italian Neurological Society. Amato MP, Goretti B, Zipoli V, Portaccio E, Centorrino S, Contri V, Lori S, Falcini M, Comi G, Moiola L, Falautano M, Trojano M, De Caro MF, Lopez M, Patti F, Vecchio R, Gallo P, Grossi P, Bertolotto A, Giampaolo S, Pozzilli C, Bianchi V, Manca I, Masia C, Bergamaschi R, Veggiotti P, Ghezzi A, Roscio M.

source: Neurology. 2008 May 13;70(20):1891-7.

read more

EXTAVIA Approved In European Union For Treatment Of Multiple Sclerosis, First In Planned Portfolio Of Therapies From Novartis
The European Commission has approved Extavia® (interferon beta-1b) for the treatment of early and relapsing forms of multiple sclerosis (MS) - the first in a new portfolio of medicines from Novartis that is planned to include both established treatments and innovative therapies for patients with MS.


vitamin D

Vitamin D levels should be multiplied by ten for children: study
NutraIngredients.com - Montpellier,France
By Stephen Daniells 28-May-2008 - Raising current vitamin D levels from 200 International Units (IU) to 2000 IU could boost bone health amongst children and ...
See all stories on this topic

Plainfield doctor touts benefits from Vitamin D
Barre Montpelier Times Argus - Barre,VT,USA
By Mel Huff Times Argus Staff MONTPELIER – A lack of vitamin D, which is produced by skin when exposed to the sun's rays, correlates with a wide variety of ...
See all stories on this topic

Current Vitamin D Recommendations Fraction Of Safe, Perhaps ...
Science Daily (press release) - USA
ScienceDaily (May 27, 2008) — The current recommended daily allowance (RDA) of vitamin D for children is 200 International Units (IUs), but new research ...
See all stories on this topic

Study looks at link between vitamin D and prostate cancer risk
The Canadian Press - TORONTO
TORONTO — A new US study contradicts the notion that high blood levels of vitamin D might help protect men from developing prostate cancer - a finding that ...
See all stories on this topic

High Doses of Vitamin D Found Safe for Adolescents
MedPage Today - Little Falls,NJ,USA
By Todd Neale, Staff Writer, MedPage Today BEIRUT, Lebanon, May 27 -- High weekly doses of vitamin D 3 for a year raise serum 25-hydroxyvitamin D levels ...
See all stories on this topic

Relationship between Low Ultraviolet B Irradiance [vitamin D] and ...
ProHealth's ImmuneSupport.com - Santa Barbara,CA,USA
Epidemiological data show an inverse relationship between vitamin D levels and breast cancer incidence. This study investigates the relationship of modeled ...
See all stories on this topic

Study: Teens should increase vitamin D
United Press International - USA
BEIRUT, Lebanon, May 27 (UPI) -- Researchers in Lebanon say teens may take 10 times the US recommended daily allowance of vitamin D of 200 International ...
See all stories on this topic

Vitamin D doesn't cut prostate cancer risk
Reuters UK - UK
By Will Dunham WASHINGTON (Reuters) - Vitamin D -- the so-called sunshine vitamin -- does not appear to cut a man's risk of getting prostate cancer, ...
See all stories on this topic

Vitamin D Status Not Associated With Lower Prostate Risk
U.S. News & World Report - Washington,DC,USA
TUESDAY, May 27 (HealthDay News) -- Men with a high blood concentration of vitamin D don't have a reduced risk of prostate cancer, National Cancer Institute ...
See all stories on this topic

More vitamin D, more benefits
Medill Reports - Washington,DC,USA
by Farah Khan WASHINGTON – Many pediatricians have been reluctant to prescribe supplementary vitamin D, worried it would be too toxic for children. ...
See all stories on this topic

Google Blogs Alert for: vitamin D

Use of vitamin D in clinical practice by by John J. Cannell, Bruce ...
By Ndut(Ndut)
The recent discovery--from a meta-analysis of 18 randomized controlled trials--that supplemental cholecalciferol (vitamin D) significantly reduces all-cause mortality emphasizes the medical, ethical, and legal implications of promptly ...
Health for All, for Life, for... - http://healthlife-ndut.blogspot.com/

Current vitamin D recommendations may be too low
New research shows that children may benefit from ten times the recommended daily allowance of vitamin D.
Contemporary Pediatrics Magazine - http://contemporarypediatrics.modernmedicine.com/contpeds

Vitamin D doesn’t cut prostate cancer risk
By admin
if vitamin D might protect against prostate cancer, the second most frequently diagnosed cancer in men worldwide. They tracked vitamin D concentrations in the blood of 749 men diagnosed with prostate cancer and 781 men who did not have ...
Health Experiment - http://www.healthexperiment.com

Relationship between Low Ultraviolet B Irradiance [vitamin D] and ...
By feeds@prohealth.com (Sarif B Mohr, Frank...
The fourth paper from this UC San Diego team adds an association between higher vitamin D3 in the body and lower breast cancer risk to similar findings for vitamin D and kidney cancer, ovarian cancer, and endometrial cancer risk. ...
ProHealth Chronic Fatigue Syndrome... - http://www.immunesupport.com

Are You Getting Enough Vitamin D?
For years companies have bombarded our senses with sensational promises to keep us young, help us lose weight, and help us fight disease....what you see on the shelf at Walgreen’s is high-priced, over-branded SnakeOil. Vitamin D ...
Digg / Health / upcoming - http://digg.com/health


multiple sclerosis stem cells

Getting Facts on Stem Cells Research
RedOrbit - Dallas,TX,USA
Visitors were also given the chance to meet charities dealing with diseases such as Parkinson's disease and multiple sclerosis. ...
See all stories on this topic

Israeli Scientists Recipients of 2008 International Adult Stem ...
PR Newswire (press release) - New York,NY,USA
... help multiple sclerosis and amyotropic lateral sclerosis patients by injecting their spinal fluid with large numbers of adult stem cells (mesenchymal ...
See all stories on this topic

Hybrid embryos vote a good start, says BIA
Pharma Times (subscription) - London,UK
Last week’s parliamentary vote in favour of using interspecies or hybrid embryos for stem cell research is welcome but needs to be backed up with funding ...
See all stories on this topic

Saving your baby's stem cells at the dentist could save their life ...
KVUE - Austin,TX,USA
And already stem cell research is being done that could eventually treat conditions like diabetes, heart disease, leukemia, multiple sclerosis, parkinson’s, ...
See all stories on this topic

Novel role for SLPI in MOG-induced EAE revealed by spinal cord ...
7thSpace Interactive (press release) - New York,NY,USA
Adult neural stem cells were incubated with recombinant secretory leukocyte protease inhibitor (SLPI). Proliferation was assessed by BrdU incorporation, ...
See all stories on this topic

BioTech Buzz: How Much Is A CEO Worth?
Worcester Business Journal - Worcester,MA,USA
... and there were two encouraging late stage product clinical trials: one for stem-cell transplantation and the other for multiple sclerosis. ...
See all stories on this topic

Wednesday, May 28, 2008

EXTAVIA Approved In European Union For Treatment Of Multiple Sclerosis, First In Planned Portfolio Of Therapies From Novartis

EXTAVIA Approved In European Union For Treatment Of Multiple Sclerosis, First In Planned Portfolio Of Therapies From Novartis
The European Commission has approved Extavia® (interferon beta-1b) for the treatment of early and relapsing forms of multiple sclerosis (MS) - the first in a new portfolio of medicines from Novartis that is planned to include both established treatments and innovative therapies for patients with MS.


Montel Show Says Goodbye
Associated Content - Denver,CO,USA
In 1999, Williams was diagnosed with Multiple Sclerosis, and has since fought to help find a cure by using his celebrity status to get the information out ...
See all stories on this topic


Novartis MS Drug, Rival to Bayer's, Wins EU Approval (Update2)
Bloomberg - USA
Fingolimod, which could be one of the first oral treatments for the disease on the market, is one of the products that may help Novartis weather the loss of ...
See all stories on this topic


New Cheaper Method For Mapping Disease Genes
Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.

Guideline: Vertigo Can Be Treated Easily And Quickly
A new guideline developed by the American Academy of Neurology found that the best treatment for vertigo is the easiest and quickest one. The guideline on benign paroxysmal positional vertigo (BPPV), an inner ear disorder that is a common cause of dizziness, is published in the May 27, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.


TYSABRI

Tysabri faces uphill battle in treating Crohn's
Irish Independent - Dublin,Ireland
By Bill Berkrot TYSABRI will have to make a significant impact on the treatment of Crohn's disease if Elan and Biogen are to hit their stated goal of 100000 ...
See all stories on this topic

Elan "add"
newratings.com - Westerburg,Germany
... if AAB-001 exhibits better efficacy than all the existing Alzheimer’s drugs in the market and if Tysabri moves towards realizing its full potential. ...
See all stories on this topic

PDL for Sale, Cheap!
Motley Fool - USA
... and the relaunch of Biogen Idec's (Nasdaq: BIIB) and Elan's (NYSE: ELN) Tysabri is going quite well. New compounds like UCB's Crohn's disease treatment ...
See all stories on this topic

Elan may spin off contract manufacturing arm
OutSourcing-Pharma.com - London,UK
Tysabri was withdrawn from the market three months after its approval in 2004 after reports of three trial volunteers developing progressive multifocal ...
See all stories on this topic


Ask the Expert - Interrogez un spécialiste

MS Answers

Treatment

Dr. Schapiro

Clinical Professor of Neurology
View BIO

Q :
I have been taking Rebif for a number of years. I need to take a blood test every six months. What exactly does the blood test analyses?
A :
All of the interferons have the potential to react in the body in ways that are not intended. We may call those reactions "side-effects" but sometimes they are silent side-effects in that we do not feel them. They are metabolized or disposed of in the liver. If they cause an over-reaction in the liver, damage to the liver may occur. We can measure whether liver damage is happening by measuring the enzymes produce by a damaged liver. We expect some elevation of the enzymes when taking interferon but if it is more than expected, a dose adjustment of the interferon is necessary. Other medications may influence the liver as well and may work in conjunction with the interferon to cause an issue. We also measure the blood count and distribution of blood cells to insure that the interferon is not producing too great an immune effect which could result in increased likelihood of infection. That is why we test these about every 6 months--trying to get ahead of any potential problem.
5/28/2008 7:32:20 AM
More answers from Dr. Randall T. Schapiro
More answers in the category: Treatment


DISCLAIMER: Please be aware that this information does not necessarily represent the opinion of the MS Society of Canada, and is not intended as medical advice. For specific advice and opinion, always consult a physician.
© 2008 Multiple Sclerosis Society of Canada | www.mssociety.ca

http://www.msanswers.ca/QuestionView.aspx?L=2&QID=1626


Ask the Expert - Interrogez un spécialiste

MS Answers

Treatment

Dr. Tremlett

Assistant professor at the University of British Columbia in the Faculty of Medicine, Division of Neurology
View BIO

Q :
I have been taking Avonex for the past two years and have responded well to the treatment. My only concern has been related to an increased amount of hair loss. In your opinion, could this be associated with the use of this medication?
A :
Yes, beta-interferon has been associated with hair loss. For instance in the Avonex® clinical trials, hair-loss affected twice as many patients receiving Avonex than those receiving placebo (ie a ‘dummy’ pill). Although the proportion of patients affected was relatively small, and people taking placebo did experience some hair-loss: 2% of people taking placebo reported hair-loss compared to 4% of those taking Avonex®.
However, there are many other causes of hair loss! Examples range from a deficiency in iron or zinc to hypothyroidism as well as many other drugs. I suggest you discuss this issue with your physician who will be familiar with your clinical history and will be able to ascertain whether there are other causes for your hair loss.
5/28/2008 7:30:17 AM
More answers from Dr. Helen Tremlett
More answers in the category: Treatment


DISCLAIMER: Please be aware that this information does not necessarily represent the opinion of the MS Society of Canada, and is not intended as medical advice. For specific advice and opinion, always consult a physician.
© 2008 Multiple Sclerosis Society of Canada | www.mssociety.ca

http://www.msanswers.ca/QuestionView.aspx?L=2&QID=1474


vitamin D

Expert: Vitamin D dilemma solved by diet
United Press International - USA
DALLAS, May 26 (UPI) -- Studies suggest vitamin D may help prevent cancer, type 1 diabetes and multiple sclerosis, but some people worry about sun exposure, ...
See all stories on this topic

Vitamin D deficiency linked to back pain
ABC7Chicago.com - IL, USA
Older women who are not getting enough Vitamin D could be at risk for suffering back pain. A new study examined nearly 1000 people ages 65 and older. ...
See all stories on this topic

Low vitamin D tied to back pain in older women
Reuters India - Mumbai,India
NEW YORK (Reuters Health) - Older women who aren't getting enough vitamin D appear to be at risk for suffering from back pain, new research shows. ...
See all stories on this topic

Vitamin D use linked to lower mortality in kidney patients
Tehran Times - Iran
Taking activated vitamin D may cut the risk of death for people with moderate to severe chronic kidney disease by about one quarter, a new study suggests. ...
See all stories on this topic

Too little sun is nearly as bad as too much
Modesto Bee - Modesto,CA,USA
While no one is suggesting we return to the days of rubbing Crisco on our bodies, many doctors now insist we need more of the sunshine vitamin -- vitamin D. ...
See all stories on this topic

Vitamin D: Good for More than Bones
By Tim(Tim)
We know that vitamin D helps the bones by preventing osteoporosis and fractures, but did you know that vitamin D also plays an important role in the prevention of many other diseases, including cancer, heart disease, autoimmune diseases ...
The Black Kettle - http://theblackkettle.blogspot.com/

Osteoporosis--Don't Forget Vitamin K2
By Dr. Neustadt(Dr. Neustadt)
While calcium and vitamin D are important, they aren't the whole story. In fact, clinical trials mostly conclude that these two nutrients decrease the rate of bone loss, but don't necessarily decrease the risk of fracture. ...
The NBI Supplement - http://www.nbihealth.com/blog/

Dr. Briffa: Does vitamin D help protect against type 1 diabetes?
By eileen
What alerted me this week to the potential link between vitamin D and type 1 diabetes was a study published on-line in the Archives of Disease in Childhood. In this study, researchers pooled together (in the form of what is known as a ...
tanTALK - http://tantalk.com


Stem Cell Research News

Bone Repair Using Patient's Stem Cells Comes Closer
Hitherto it has been difficult to induce adult human stem cells to produce bone, e.g. in order to repair bone tissue. Researchers at the University of Twente have shown that if the enzyme PKA is previously activated in the stem cells in the lab, following implantation this results in substantial bone formation.

Stem cell enhancers

The Ultimate Cure
Conde Nast Portfolio - New York,NY,USA
In previous studies with mice, the stem cells took hold and produced the missing enzyme. “These trials are just the beginning for stem-cell therapies in the ...
See all stories on this topic

Preclinical Data Demonstrate Ability To Regenerate An Entire Bladder With Tengion Neo-Bladder Replacement(TM)
Tengion, Inc., a clinical stage biotechnology company focused on the development of neo-organs and neo-vessels, presented preclinical efficacy data for its Tengion Neo-Bladder Replacement™ at the Annual Meeting of the American Urological Association (AUA) in Orlando, Florida on May 18, 2008.


McMaster Daily News

McMaster University

Hendrik Poinar, Christopher Wynder and Sheila Singh are McMaster's newest Canada Research Chairs. File photos.

Hendrik Poinar, Christopher Wynder and Sheila Singh are McMaster's newest Canada Research Chairs. File photos.

Three more Canada Research Chairs for McMaster

by Danelle D'Alvise, Research Communications
December 17, 2007

McMaster's newly minted Canada Research Chairs are three young researchers who weren't even born when their respective fields were first explored by pioneering scientists during the 1960s.

Today, their areas of research are the subject of headlines and the focus of scientists the world over -- a reflection of the potential and promise of the fields of paleogenetics and human stem cell biology.

Hendrik Poinar, Sheila Singh and Christopher Wynder share the same passion for unlocking the genetic mysteries of disease, but each views this research challenge through significantly different lenses.

Hendrik Poinar sees through the lens of a molecular evolutionary geneticist, using ancient DNA to answer questions about evolution and environments from samples that can be several million years old.

An associate professor in the Department of Anthropology and the Department of Pathology and Molecular Medicine, Poinar is now a Canada Research Chair in Paleogenetics. The science of paleogenetics -- a term first coined by Nobel laureate Linus Pauling in 1963 -- applies genetics to paleontology.

Poinar has established a world-class molecular anthropology lab that is devising novel techniques to extract information from ancient DNA. His work sequencing the genome of the woolly mammoth represents just one aspect of the research he does with his team in the McMaster Ancient DNA Centre.

Poinar is also focused on determining the timing and origin of the human immunodeficiency virus (HIV) from some of the oldest samples of archival HIV collected between 1959 and 1980. In addition, Poinar's research program aims to better understand the evolution of pandemic infections to help track the spread of future infectious diseases and aid in developing the appropriate vaccines.

While Poinar's research involves using DNA to unlock the mysteries of the past and better understand how to combat infectious diseases of the future, Christopher Wynder and Sheila Singh seek to unlock the mystery of the stem cells at the root of cancer -- a disease that is one of the leading causes of death in the world.

Canadian scientists first proved the existence of stem cells in 1961 and since then, significant research in the field has identified the importance of human embryonic stem cells and their role in producing the starting material for every organ and tissue in our body.

Stem cells have the ability to continuously reproduce themselves and one of the challenges for Wynder and Singh -- both scientists in the McMaster Stem Cell and Cancer Research Institute (SCCRI) -- is to determine why some stem cells multiply normally while others give rise to cancer.

As Canada Research Chair in Epigenetic Control of Stem Cells, Wynder's research involves determining the interplay of different factors within stem cells that affect the decision on whether to multiply. Knowing how a stem cell first mutates into a cancerous cell may lead to the ability to better assess what factors lead to the development of cancerous tumours.

Wynder, an assistant professor in the Department of Biochemistry and Biomedical Sciences, will study the protein known as histone demethylases to determine what role it plays in telling a stem cell to multiply or differentiate.

Sheila Singh's Canada Research Chair in Human Cancer Stem Cell Biology provides the pediatric neurosurgeon further opportunity to combine her work as a surgeon with her work as a research scientist to discover more about the formation of brain tumours -- the leading cause of cancer mortality in children.

Singh, an assistant professor in the Department of Surgery, neurosurgery division, has discovered an abnormal stem cell -- the brain tumour initiating cell (BTIC) -- that may drive the formation of brain tumours. These BTICs are rare and represent only a small fraction of the whole tumour, but these cells alone may be entirely responsible for the continued growth of the tumour.

By isolating this rare tumour stem cell and exploring the concept that not every cell in a brain tumour is capable of fueling a tumour's growth, Singh and her team will be on the leading edge of the research that will aid in predicting the patient's survival rate. Singh's work will also lead to the development of therapies to target the cells that initiate the brain tumour.

Mo Elbestawi, vice-president, research and international affairs, notes that it is particularly satisfying to have the opportunity to offer Tier 2 Canada Research Chairs to each of these three researchers.

"Tier 2 Chairs are offered to 'exceptional emerging researchers' and certainly, it's clear that all three have established themselves as a key force in their respective research field, poised for even greater success," says Elbestawi. "McMaster recognized the promise of Hendrik Poinar and was fortunate to recruit him in 2003 and now, keep him here to continue his landmark research. Our world-class Stem Cell and Cancer Research Institute and the Chairs program drew Christopher Wynder and Sheila Singh to further advance the Institute's pioneering science. We're going to be seeing great things from these three -- our University is fortunate to have these 'bright lights' on board."

There are two types of Canada Research Chairs:

Tier 1 Chairs, tenable for seven years and renewable, are for outstanding researchers acknowledged by their peers as world leaders in their fields. For each Tier 1 Chair, the university receives $200,000 annually for seven years.

Tier 2 Chairs, tenable for five years and renewable once, are for exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field. For each Tier 2 Chair, the university receives $100,000 annually for five years.

The following researchers had their Tier 1 Canada Research Chairs renewed:

  • David Andrews Canada Research Chair in Membrane Biogenesis
  • Walter Craig Canada Research Chair in Mathematical Analysis and its Applications
  • Adam Hitchcock , Canadian Light Source - Canada Research Chair for Materials Analysis
  • Geoffrey R. Norman, Canada Research Chair in Cognitive Dimensions of Clinical Expertise
  • Peter L. Rosenbaum, Canada Research Chair in Childhood Disability Research, Dissemination and Mentoring
  • Christopher M. Wood, Canada Research Chair in Environment and Health

    "As demonstrated in Mobilizing Science and Technology to Canada's Advantage, the Government of Canada is committed to improving Canada's international reputation for research excellence," said the Honourable Jim Prentice, Minister of Industry and Minister responsible for the Canada Research Chairs Program. "By investing in the Canada Research Chairs Program, we are helping universities recruit and retain the most brilliant and promising researchers, and contributing to enable these institutions to become leaders in the fields of advanced science and technology."

  • http://dailynews.mcmaster.ca/story.cfm?id=5115

    Tuesday, May 27, 2008

    Novartis' MS drug Extavia gains approval in EU

    Novartis' MS drug Extavia gains approval in EU
    The Money Times - Mumbai,Maharashtra,India
    ... means we are able to offer the MS community a current standard of care while preparing for the introduction of innovative therapies such as FTY720. ...
    See all stories on this topic

    Novartis MS Drug, Rival to Bayer's, Wins Approval (Update1)
    Bloomberg - USA
    By Dermot Doherty May 26 (Bloomberg) -- Novartis AG, Switzerland's second- biggest drugmaker, won European regulatory approval for its Extavia multiple ...
    See all stories on this topic

    UPDATE 1-Novartis' MS drug gets approval in EU
    Reuters - USA
    Extavia will give Novartis an important presence in MS treatment before the submission of its once-daily therapy FTY720 (fingolimod). ...
    See all stories on this topic

    Extavia® Approved In European Union For Treatment Of Multiple ...
    ABN Newswire (press release) - Sydney,NSW,Australia
    By the end of 2009, Novartis also plans to file for approval of the innovative oral therapy FTY720 (fingolimod). Results of an ongoing Phase II study ...
    See all stories on this topic


    Ask the Expert - Interrogez un spécialiste

    MS Answers

    Research

    Dr. O'Connor

    Neurologist, MS Clinic at St. Michael's Hospital in Toronto, ON
    View BIO


    Q :
    If a person dies having been diagnosed with MS, what data is collected and by who?
    A :
    That all depends on whether the body of the person with MS is subject to a medical examination after death (an autopsy). The decision to request an autopsy usually comes from the next of kin, although in rare circumstances the coroner can order one. Religious practice, custom, and the deceased person's wishes in this regard are all important factors in what happens. Most of the time, an autopsy is not performed.
    5/26/2008 10:01:02 PM
    More answers from Dr. Paul O'Connor
    More answers in the category: Research
    For more information related to this topic, please click Research Page

    http://www.msanswers.ca/QuestionView.aspx?L=2&QID=816

    Tysabri

    Tysabri faces uphill battle in Crohn's disease
    Reuters - USA
    O: Quote, Profile, Research) to hit its stated goal of 100000 patients on Tysabri by 2010. But it faces an uphill battle as a treatment for the bowel ...
    See all stories on this topic

    Elan mulls separate listing for EDT unit -report
    Reuters - USA
    ... in February that Elan was considering splitting its bio-pharmaceuticals arm, which markets its flagship multiple sclerosis drug Tysabri, from EDT. ...
    See all stories on this topic

    Elan confident of posting healthy profits in two years' time
    Pharma Times (subscription) - London,UK
    Ireland’s Elan Corp has reiterated its faith in reaching a target of 100000 patients for its multiple sclerosis drug Tysabri by the end of 2010. ...
    See all stories on this topic

    Novartis MS Drug, Rival to Bayer's, Wins EU Approval (Update3)
    Bloomberg - USA
    ... Idec Inc.'s Avonex, Merck Serono SA's Rebif, Teva Pharmaceutical Industries Ltd.'s Copaxone and Elan Corp. and Biogen's Tysabri for share of the MS market.
    See all stories on this topic

    Monday, May 26, 2008

    Access all areas

    Access all areas
    Liverpool Echo - UK
    Christine has multiple sclerosis and is confined to a wheelchair. The original APR website was the first in the UK to specialise exclusively in promoting ...
    See all stories on this topic


    Board: Deck may need to be torn down
    Leader-Telegram - Eau Claire,WI,USA
    The old deck was worn out, and Stanley, who is in a motorized wheelchair because of multiple sclerosis, needed a ramp. Stanley and Hibbard replaced the deck ...
    See all stories on this topic

    Patients Ask Lawmakers to Allow Pot Use
    RedOrbit - Dallas,TX,USA
    In June 2006, the state Senate health committee was discussing a similar bill and heard impassioned testimony from TV personality Montel Williams, ...
    See all stories on this topic


    'Missed' Biochemical Pathway Emerges As Important In Virtually All Cells
    A new study by Duke University researchers provides more evidence that the nitric oxide (NO) system in the life of a cell plays a key role in disease, and the findings point to ways to improve treatment of illnesses such as heart disease and cancer.
    Stem cell experts explain the science
    The Northern Echo - Darlington,UK
    ... the public the chance to meet stem cell scientists and representatives from charities dealing with diseases such as Parkinson's and Multiple Sclerosis. ...
    See all stories on this topic

    vitamin D

    Taking Vitamin D May Reduce Diabetes Risk
    findingDulcinea - New York,New York,USA
    by findingDulcinea Staff A study suggests children who take vitamin D are less likely to develop type 1 diabetes as adults. Diabetes affects millions and ...
    See all stories on this topic

    Tests suggest many UAE residents suffer from Vitamin D deficiency
    GulfNews - Dubai,United Arab Emirates
    Abu Dhabi: Sixty five per cent of females and sixty per cent of males in the UAE suffer from Vitamin D deficiency, lab tests at the Shaikh Khalifa Medical ...
    See all stories on this topic

    Vitamin D Deficiency: Information for Cancer Patients
    PR Web (press release) - Ferndale,WA,USA
    Cancer patients need to communicate with their physician about the test for vitamin D deficiency, symptoms of vitamin D deficiency and how to maintain the ...
    See all stories on this topic

    Saturday, May 24, 2008

    Dabur Pharma gets USFDA approval for selling ‘Mitoxantrone HCL’
    Stock Watch - Noida,Uttar Pradesh,India
    ... of clinical relapses in patients with secondary chronic progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (ie, ...
    See all stories on this topic

    The Boat
    San Francisco Chronicle - CA, USA
    ... Jamie and his younger brother (and by extension their fisherman father) struggle with the knowledge that their mother is dying of multiple sclerosis. ...
    See all stories on this topic

    Time for another term
    Cumberland News - Carlisle,England,UK
    The challenge of representing such a vast area increased when the MP was diagnosed with multiple sclerosis. He struggles to walk further than a few yards ...
    See all stories on this topic

    Teach Your Kid How to Sense BS
    Town Hall - Washington,DC,USA
    The evening benefits The Nancy Davis Foundation for Multiple Sclerosis. REUTERS/Mario Anzuoni (UNITED STATES) How many of you have met the book smart 4.0 ...
    See all stories on this topic

    Montel Williams multiple sclerosis

    NJ lawmakers consider medical marijuana bill
    Newsday - Long Island,NY,USA
    ... panel heard from television personality Montel Williams and other advocates two years ago during an information session. Williams, a multiple sclerosis ...
    See all stories on this topic

    THE 12:30 REPORT: Your News Update
    Philadelphia Magazine's Daily Examiner - Philadelphia,PA,USA
    The Assembly heard from medicinal marijuana advocates such as Montel Williams, who uses the drug to alleviate symptoms of multiple sclerosis. ...
    See all stories on this topic

    TRENTON: Lawmaker consider legalizing marijuana for some residents
    Vineland Daily Journal - Vineland,NJ,USA
    However, a Senate health panel heard from television personality Montel Williams and other advocates two years ago during an information session. ...
    See all stories on this topic

    Cedar Creek Elementary School a scheduled stop on annual bike tour
    Asbury Park Press - Asbury Park,NJ,USA
    He's 24 now," she said of her son, Joe McGavley, who met with talk show host Montel Williams. "He did a commercial with him about MS and is also mentioned ...
    See all stories on this topic

    Notch Multiple Sclerosis

    Watson & Clayton Top The Rivenhall Charts
    Elimar Pigeon Services - Middlewich,England,UK
    This weeks race was the Multiple Sclerosis Therapy Centre, South Bank Charity event, the second event will be from young bird Rivenhall. ...
    See all stories on this topic

    human gene therapy trial in MS

    Gene therapy offers hope for hereditary blindness
    OSN SuperSite (subscription) - Thorofare,NJ,USA
    Both studies represent the first successful application of gene therapy in human patients for the debilitating retinal condition. ...
    See all stories on this topic

    When Bad Evidence Happens to Good Treatments
    RedOrbit - Dallas,TX,USA
    Ironically, as the Human Genome Project has generated optimism about tomorrow's personalized medicine based upon pharmaco-genomics,11 the already ...
    See all stories on this topic

    April 2000 archives, part 3
    Overlawyered - New York,NY,USA
    Lively discussion breaks out on Motley Fool investment bulletin boards concerning suit filed by class-action filers Milberg Weiss against genome-mapping ...
    See all stories on this topic

    How Stem Cells Decide What They'll Be
    How does a stem cell decide what specialized identity to adopt - or simply to remain a stem cell? A new study suggests that the conventional view, which assumes that cells are "instructed" to progress along prescribed signaling pathways, is too simplistic.

    World’s first stem cell ‘library’ on deck at McMaster
    McMaster's Stem Cell & Cancer Research Institute is the only facility in Canada dedicated to human embryonic stem cell research. ...

    The ground state of embryonic stem cell self-renewal : Abstract ...
    Center for Stem Cell and Regenerative Medicine, Department of Cell and ... McMaster Stem Cell and Cancer Research Institute, McMaster University, ...

    The Emerging Role Of Infection In Alzheimer's Disease
    A number of chronic diseases are in fact caused by one or more infectious agents. For example, stomach ulcers are caused by Helicobacter pylori, chronic lung disease in newborns and chronic asthma in adults are both caused by Mycoplasmas and Chlamydia pneumonia, while some other pathogens have been associated with atherosclerosis.


    AMA Applauds Passage Of New Law To Protect Patients From Genetic Discrimination
    "Patients in the U.S. are now protected against genetic discrimination because of a new law to keep their genetic information secure. The American Medical Association has long called for better patient privacy safeguards as scientific advancements make it possible to individualize health care for patients.

    RNA Toxicity Contributes To Neurodegenerative Disease, University Of Pennsylvania Scientists Say
    Expanding on prior research performed at the University of Pennsylvania, Penn biologists have determined that faulty RNA, the blueprint that creates mutated, toxic proteins, contributes to a family of neurodegenerative disorders in humans.

    At The Synapse: Gene May Shed Light On Neurological Disorders
    In our brains, where millions of signals move across a network of neurons like runners in a relay race, all the critical baton passes take place at synapses. These small gaps between nerve cell endings have to be just the right size for messages to transmit properly.












    Discovery Of Gatekeepers In The Human Cell 'Shredder' Could Lead To A New Target For Cancer Drugs
    Insulin, a hormone released in large quantities when food is consumed, is reduced by 50% only three to five minutes later. However, if the cell's internal waste disposal system malfunctions, illnesses such as Alzheimer's or Parkinson's disease may occur.

    They won't be brushed off

    They won't be brushed off
    KeepMEcurrent.com - Scarborough,ME,USA
    Those with the three more severe stages, called Primary-Progressive MS, Secondary-Progressive MS and Progressive-Relapsing MS, could steadily have more ...
    See all stories on this topic


    Opexa Therapeutics Presents Myelin Reactive T-Cell Research at the ...
    Business Wire (press release) - San Francisco,CA,USA
    Patient-specific T-cell lines for Tovaxin® vaccine formulation are then generated using synthetic peptides across myelin basic protein, proteolipid protein, ...
    See all stories on this topic

    Opexa Therapeutics presents Persistence of Myelin Reactive T-cells ...
    RTT News - Williamsville,NY,USA
    Patient-specific T-cell lines for Tovaxin vaccine formulation are then generated using synthetic peptides across myelin basic protein, proteolipid protein, ...
    See all stories on this topic


    The words no one ever wants to hear
    Taunton Daily Gazette - MA, USA
    Originally, my doctor was looking for symptoms of multiple sclerosis. Kennedy is a lucky man in that he has a loyal and very strong family. ...
    See all stories on this topic

    Posted by Jacob Goldstein
    Wall Street Journal Blogs - New York,NY,USA
    Ron Cohen, CEO of Acorda Therapeutics, talked with the Health Blog about the landscape for MS treatment and the prospects for Fampridine-SR, a medicine his ...
    See all stories on this topic

    MS Society Calls On MPs To Support New Avenues Of Research, UK
    Medical News Today (press release) - UK
    "At the moment, there are limited options for scientists investigating the use of stem cells and as a result, their full potential is yet to be realised. ...
    See all stories on this topic

    Invitrogen venture further into cell therapy with new unit
    LabTechnologist.com - London,UK
    Q Therapeutics develops cell-based therapies for a variety of central nervous system and neurodegenerative diseases, such as multiple sclerosis, ...
    See all stories on this topic

    Health & Medicine
    Investor's Business Daily (subscription) - USA
    Privately held Bay Hill Therapeutics of Palo Alto, Calif. is attacking the same issue with a gene
    therapy approach. It also has some promise, Richert says. ...
    See all stories on this topic


    Tysabri

    UPDATE 1-Elan says on track to meet profit, sales goals
    Reuters - USA
    The Dublin-based group also repeated it expected to make a profit in 2010 thanks to growing sales of its flagship multiple sclerosis (MS) drug Tysabri. ...
    See all stories on this topic

    Elan reaffirms core loss guidance, sees sales boost
    Reuters - USA
    DUBLIN, May 22 (Reuters) - Elan Corp (ELN.I: Quote, Profile, Research)(ELN.L: Quote, Profile, Research) Chief Executive Kelly Martin reaffirmed on Thursday ...
    See all stories on this topic

    Elan revenues in first quarter boosted by Tysabri MS drug; Loss ...
    FinFacts Ireland - Ireland
    By Finfacts Team Elan Corporation, today announced its first quarter 2008 financial results, which were boosted by Tysabri sales and provided a business ...
    See all stories on this topic

    Elan revenues boosted by Tysabri sales
    Ireland Digital - UK
    Elan Corp., the Irish drugmaker, yesterday announced its first quarter 2008 financial results, which were boosted by sales of the MS drug Tysabri. ...
    See all stories on this topic

    Elan aiming for profit by 2010 with Tsyabri sales
    Irish Independent - Dublin,Ireland
    By Sharon Lynch Elan said yesterday it expects to make a profit by 2010 and to reach its patient target for its multiple-sclerosis drug Tysabri by that year ...
    See all stories on this topic

    Elan CEO: Tysabri Use Accelerating From 26000 Patients In 1Q
    CNNMoney.com - USA
    PLC (ELN) Chief Executive Kelly Martin said the number of patients on multiple sclerosis drug Tysabri was "accelerating" from the 26000 patients recorded in ...
    See all stories on this topic

    neuroregeneration strategies

    Astroglia: Not Just Glue
    Journal of Neuropsychiatry (subscription) - USA
    ... Wahlberg L: Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson’s diseases? ...
    See all stories on this topic

    Vitamin D is Good for More Than Just Bones
    RedOrbit - Dallas,TX,USA
    We know that vitamin D helps the bones by preventing osteoporosis and fractures, but did you know that vitamin D also plays an important role in the ...
    See all stories on this topic


    Anti Inflammatory Medication May Treat Type 2 Diabetes
    Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.

    Healthcare Activists Plan June 19th As National Day Of Action Against Health Insurance Companies, California
    Thousands to Gather in San Francisco and Around Country as 38,000 Insurance Industry Executives Meet for Annual AHIP ConventionNurses, Doctors, Patients, Consumer Activists Call for Guaranteed, Single-Payer Healthcare-"Patients Not Profits" Seeking an end to the healthcare crisis that is destroying American lives and families, thousands of healthcare activists will descend on San Francisco and on cities around the country this June 19th as part of an unprecedented national day of protests against health insurance corporations-and in support of guaranteed, single-payerhealthcare, the "Medicare for All" system succeeding in nearly every other industrialized democracy.

    NARSAD Researchers Showcase New Treatment Options For Severe Depression; Provide New Clues About Treating Clinical Anxiety And Schizophrenia
    New findings from research supported by NARSAD, the world's leading charity dedicated to mental health research, and conducted by scientists at Washington University's School of Medicine (WUSM) now point to new options for treating preschool-aged children with significant clinical depression as well as those severely depressed adults who don't respond to standard treatments, such as antidepressants and psychotherapy.


    Troubled teens motivated by music
    MiamiHerald.com - Miami,FL,USA
    ''For me, music is therapeutic,'' she said. ``It's powerful. If I'm having a bad day, the right song can completely change my mood. ...
    See all stories on this topic